354 related articles for article (PubMed ID: 30944472)
1. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for acetyl-CoA production by ATP-citrate lyase.
Wei X; Schultz K; Bazilevsky GA; Vogt A; Marmorstein R
Nat Struct Mol Biol; 2020 Jan; 27(1):33-41. PubMed ID: 31873304
[TBL] [Abstract][Full Text] [Related]
3. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
4. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis.
Bazilevsky GA; Affronti HC; Wei X; Campbell SL; Wellen KE; Marmorstein R
J Biol Chem; 2019 May; 294(18):7259-7268. PubMed ID: 30877197
[TBL] [Abstract][Full Text] [Related]
5. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
[TBL] [Abstract][Full Text] [Related]
6. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography.
Sun T; Hayakawa K; Bateman KS; Fraser ME
J Biol Chem; 2010 Aug; 285(35):27418-27428. PubMed ID: 20558738
[TBL] [Abstract][Full Text] [Related]
7. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
8. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
9. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
Burke AC; Huff MW
Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
[TBL] [Abstract][Full Text] [Related]
10. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
Front Immunol; 2018; 9():2858. PubMed ID: 30568658
[TBL] [Abstract][Full Text] [Related]
11. Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion.
Nguyen VH; Singh N; Medina A; Usón I; Fraser ME
Protein Sci; 2019 Oct; 28(10):1840-1849. PubMed ID: 31411782
[TBL] [Abstract][Full Text] [Related]
12. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
Koerner SK; Hanai JI; Bai S; Jernigan FE; Oki M; Komaba C; Shuto E; Sukhatme VP; Sun L
Eur J Med Chem; 2017 Jan; 126():920-928. PubMed ID: 27997879
[TBL] [Abstract][Full Text] [Related]
14. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
[TBL] [Abstract][Full Text] [Related]
15. Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes.
Chen LY; Lotz M; Terkeltaub R; Liu-Bryan R
J Biol Chem; 2018 Aug; 293(31):12259-12270. PubMed ID: 29929979
[TBL] [Abstract][Full Text] [Related]
16. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.
Zang Y; Tai L; Hu Y; Wang Y; Sun H; Wen X; Yuan H; Dai L
J Chem Inf Model; 2022 Jun; 62(12):3123-3132. PubMed ID: 35679529
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Allosteric Inhibition of Human ATP-Citrate Lyase.
Granchi C
Trends Pharmacol Sci; 2019 Jun; 40(6):364-366. PubMed ID: 31072639
[TBL] [Abstract][Full Text] [Related]
19. Allosteric role of the citrate synthase homology domain of ATP citrate lyase.
Wei X; Schultz K; Pepper HL; Megill E; Vogt A; Snyder NW; Marmorstein R
Nat Commun; 2023 Apr; 14(1):2247. PubMed ID: 37076498
[TBL] [Abstract][Full Text] [Related]
20. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
Zaidi N; Royaux I; Swinnen JV; Smans K
Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
